Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice. (Q45877184)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2-/-IL2Rγnull Immunodeficient Mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author

José Luis Pérez-Gracia

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Carlos Alfaro

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Manuel Hidalgo

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Carmen Oñate

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

3

Kurt A Schalper

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ignacio Melero, MD-PhD

17

object named as

Ignacio Melero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Miguel F Sanmamed

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Inmaculada Rodriguez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Arantza Azpilikueta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Maria E Rodriguez-Ruiz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Aizea Morales-Kastresana

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sara Labiano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Salvador Martín-Algarra

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Guillermo Mazzolini

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Francesca Sarno

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Alan J Korman

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Maria Jure-Kunkel

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

language of work or name

English

0 references

publication date

25 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

3466-3478

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer

18 February 2020

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1172/JCI61226

Targeting CD137 enhances the efficacy of cetuximab.

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1172/JCI73014

CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1182/BLOOD-2010-08-301945

Identifiers

DOI

10.1158/0008-5472.CAN-14-3510

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26113085%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference